The CAHR programme is hugely innovative. The need for harm reduction services in the five countries is clear, with evidence available from around the world to support a harm reduction approach.

What is less well understood is precisely how these services can work best in these settings, and what their overall impact will be on the people and communities involved.

The CAHR programme has partnered with the London School of Hygiene and Tropical Medicine (LSHTM) to allow in-depth research in to these issues.

This research will ensure both that the CAHR programme evolves and adapts to developing experience, but also that the lessons from the CAHR programme are made widely available to other communities to also implement harm reduction services.

The CAHR research has two key parts:

  1. The Access to Care study in Kenya, which is exploring how people who inject drugs experience HIV care and harm reduction services, and how social contexts influence this access.
  2. Operations research across the five countries, that is aiming to learn lessons about specific service delivery issues. Both areas of research will be crucial in shaping the ongoing development of services.